Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46

Reuters02-06

Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46

Encompass Health Corporation reported its results for the fourth quarter (Q4) of 2025. Net operating revenue for Q4 2025 was USD 1.54 billion, reflecting a 9.9% increase. Net income attributable to shareholders for the period was USD 146.1 million. Diluted earnings per share from continuing operations reached USD 1.42, with a 20.3% increase, while adjusted earnings per share were USD 1.46, up by 24.8%. Cash flows provided by operating activities for the quarter totaled USD 346.0 million. The company also issued its 2026 guidance, projecting adjusted earnings per share attributable to Encompass Health in the range of USD 5.81 to USD 6.10. Supplemental information and additional details regarding the quarter and outlook are available on the company’s investor relations website. Encompass Health remains the largest owner and operator of inpatient rehabilitation hospitals in the United States.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL80977) on February 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2609615582?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 05:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609615582","market":"nz","top_or_hot":-1,"title":"Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/EHC\">Encompass Health Corporation</a> reported its results for the fourth quarter (Q4) of 2025. Net operating revenue for Q4 2025 was USD 1.54 billion, reflecting a 9.9% increase. Net income attributable to shareholders for the period was USD 146.1 million. Diluted earnings per share from continuing operations reached USD 1.42, with a 20.3% increase, while adjusted earnings per share were USD 1.46, up by 24.8%. Cash flows provided by operating activities for the quarter totaled USD 346.0 million. The company also issued its 2026 guidance, projecting adjusted earnings per share attributable to Encompass <a href=\"https://laohu8.com/S/HIT\">Health in</a> the range of USD 5.81 to USD 6.10. Supplemental information and additional details regarding the quarter and outlook are available on the company’s investor relations website. Encompass Health remains the largest owner and operator of inpatient rehabilitation hospitals in the United States.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL80977) on February 05, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEncompass Health Q4 adjusted EPS rises 24.8% to USD 1.46\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-06 05:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/EHC\">Encompass Health Corporation</a> reported its results for the fourth quarter (Q4) of 2025. Net operating revenue for Q4 2025 was USD 1.54 billion, reflecting a 9.9% increase. Net income attributable to shareholders for the period was USD 146.1 million. Diluted earnings per share from continuing operations reached USD 1.42, with a 20.3% increase, while adjusted earnings per share were USD 1.46, up by 24.8%. Cash flows provided by operating activities for the quarter totaled USD 346.0 million. The company also issued its 2026 guidance, projecting adjusted earnings per share attributable to Encompass <a href=\"https://laohu8.com/S/HIT\">Health in</a> the range of USD 5.81 to USD 6.10. Supplemental information and additional details regarding the quarter and outlook are available on the company’s investor relations website. Encompass Health remains the largest owner and operator of inpatient rehabilitation hospitals in the United States.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL80977) on February 05, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1983260115.SGD","symbol_name":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL8WMBf7:1","article_id":"2609615582","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609615582","pubTimestamp":1770326466,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Encompass Health Corporation reported its results for the fourth quarter  of 2025. Net operating revenue for Q4 2025 was USD 1.54 billion, reflecting a 9.9% increase. Net income attributable to shareholders for the period was USD 146.1 million. Diluted earnings per share from continuing operations reached USD 1.42, with a 20.3% increase, while adjusted earnings per share were USD 1.46, up by 24.8%. Cash flows provided by operating activities for the quarter totaled USD 346.0 million. The company also issued its 2026 guidance, projecting adjusted earnings per share attributable to Encompass Health in the range of USD 5.81 to USD 6.10. Supplemental information and additional details regarding the quarter and outlook are available on the company’s investor relations website. Encompass Health remains the largest owner and operator of inpatient rehabilitation hospitals in the United States.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","EHC":"Encompass Health Corporation","LU0054578231.USD":"BGF SYSTEMATIC SUSTAINABLE GLOBAL SMALLCAP \"A2\" (USD) ACC","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","BK4185":"保健护理机构"},"translate_title":"Encompass Health第四季度调整后每股收益增长24.8%至1.46美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EHC":0.9},"content_text":"Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46\n    \n\nEncompass Health Corporation reported its results for the fourth quarter (Q4) of 2025. Net operating revenue for Q4 2025 was USD 1.54 billion, reflecting a 9.9% increase. Net income attributable to shareholders for the period was USD 146.1 million. Diluted earnings per share from continuing operations reached USD 1.42, with a 20.3% increase, while adjusted earnings per share were USD 1.46, up by 24.8%. Cash flows provided by operating activities for the quarter totaled USD 346.0 million. The company also issued its 2026 guidance, projecting adjusted earnings per share attributable to Encompass Health in the range of USD 5.81 to USD 6.10. Supplemental information and additional details regarding the quarter and outlook are available on the company’s investor relations website. Encompass Health remains the largest owner and operator of inpatient rehabilitation hospitals in the United States.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL80977) on February 05, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2609615582","isCrawlerRequest":true}